Dihydromyricetin ameliorates hyperuricemia through inhibiting uric acid reabsorption
- 9 April 2025
- journal article
- Published by Wiley in Journal of the Science of Food and Agriculture
- Vol. 105 (8) , 4178-4190
Abstract
BACKGROUND: Hyperuricemia (HUA) is a chronic disease caused by abnormal purine metabolism with high prevalence. Dihydromyricetin (DMY) is a natural flavonoid that is abundant in plants, such as vine tea, grapes and bayberry. DMY has been shown to possess multiple biological properties, but its anti‐HUA effect remains underexplored. In the present study, the regulatory effects of DMY on HUA and its complications and mechanism were investigated.RESULTS: DMY (10 and 20 μmol L−1) treatment significantly reduced xanthine oxidase (XOD) expression and uric acid (UA) synthesis in normal human liver cell strain cells, and intraperitoneal administration of DMY (100 mg kg−1) also significantly reduced serum UA and the expression of hepatic XOD in HUA mice. After DMY treatment for 12 consecutive days, the uricosuric protein, ATP‐binding cassette subfamily G member 2, was upregulated, and reabsorption proteins, including urate transporter 1 and glucose transporter 9, were downregulated, which was consistent with the results of monosodium urate‐induced HUA in human renal tubular epithelial cell line and human colon adenocarcinoma cell line cell models. In addition, DMY significantly ameliorated HUA‐induced renal injury, and foot edema induced by monosodium urate. The nucleotide‐binding oligomerization domain‐like receptor family containing pyrin domain 3 (NLRP3) inflammasome was activated in HUA mice as evidenced by upregulation of NLRP3, caspase‐1, ACS, TNF‐α and IL‐1β in the kidney and foot, which was significantly suppressed by DMY treatment.CONCLUSION: Collectively, these findings suggested that DMY may play important roles in experimental HUA. © 2025 Society of Chemical Industry.Keywords
This publication has 39 references indexed in Scilit:
- The structures of two glucomannans from Bletilla formosana and their protective effect on inflammation via inhibiting NF-κB pathwayCarbohydrate Polymers, 2022
- Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolismPharmacological Research, 2021
- Isoorientin exerts a urate-lowering effect through inhibition of xanthine oxidase and regulation of the TLR4-NLRP3 inflammasome signaling pathwayJournal of Natural Medicines, 2020
- Fabrication and characterization of dihydromyricetin encapsulated zein-caseinate nanoparticles and its bioavailability in ratFood Chemistry, 2020
- In vitro and in vivo anti-inflammatory effects of different extracts from Epigynum auritum through down-regulation of NF-κB and MAPK signaling pathwaysJournal of Ethnopharmacology, 2020
- Modulation of SIRT1-mediated signaling cascades in the liver contributes to the amelioration of nonalcoholic steatohepatitis in high fat fed middle-aged LDL receptor knockout mice by dihydromyricetinBiochemical Pharmacology, 2020
- Pharmacologic inducers of the uric acid exporter ABCG2 as potential drugs for treatment of gouty arthritisAsian Journal of Pharmaceutical Sciences, 2020
- Ellagic acid protects ovariectomy‐induced bone loss in mice by inhibiting osteoclast differentiation and bone resorptionJournal of Cellular Physiology, 2020
- Dihydromyricetin inhibits NLRP3 inflammasome‐dependent pyroptosis by activating the Nrf2 signaling pathway in vascular endothelial cellsBioFactors, 2017
- Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanismJournal of Hepatology, 2016